428 related articles for article (PubMed ID: 33515559)
1. A review on advances of treatment modalities for Alzheimer's disease.
Se Thoe E; Fauzi A; Tang YQ; Chamyuang S; Chia AYY
Life Sci; 2021 Jul; 276():119129. PubMed ID: 33515559
[TBL] [Abstract][Full Text] [Related]
2. Newer modalities in the management of Alzheimer's dementia along with the role of aducanumab and lecanemab in the treatment of its refractory cases.
Marsool MDM; Prajjwal P; Reddy YB; Marsool ADM; Lam JR; Nandwana V
Dis Mon; 2023 May; 69(5):101547. PubMed ID: 36931947
[TBL] [Abstract][Full Text] [Related]
3. Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective.
Ahmad J; Akhter S; Rizwanullah M; Khan MA; Pigeon L; Addo RT; Greig NH; Midoux P; Pichon C; Kamal MA
Curr Alzheimer Res; 2017; 14(11):1164-1181. PubMed ID: 28482786
[TBL] [Abstract][Full Text] [Related]
4. The Potential Benefits of Nanotechnology in Treating Alzheimer's Disease.
Ling TS; Chandrasegaran S; Xuan LZ; Suan TL; Elaine E; Nathan DV; Chai YH; Gunasekaran B; Salvamani S
Biomed Res Int; 2021; 2021():5550938. PubMed ID: 34285915
[TBL] [Abstract][Full Text] [Related]
5. Novel therapeutic strategies for Alzheimer's disease: Implications from cell-based therapy and nanotherapy.
Derakhshankhah H; Sajadimajd S; Jafari S; Izadi Z; Sarvari S; Sharifi M; Falahati M; Moakedi F; Muganda WCA; Müller M; Raoufi M; Presley JF
Nanomedicine; 2020 Feb; 24():102149. PubMed ID: 31927133
[TBL] [Abstract][Full Text] [Related]
6. Improved cognitive and memory abilities in a patient with Alzheimer's disease treated with activated immune cells: Immune cell therapy may benefit more AD patients.
Laumbacher B; Fellerhoff-Loesch B; Wank R
Med Hypotheses; 2017 Feb; 99():19-22. PubMed ID: 28110690
[TBL] [Abstract][Full Text] [Related]
7. Quantum dots as a theranostic approach in Alzheimer's disease: a systematic review.
Villalva MD; Agarwal V; Ulanova M; Sachdev PS; Braidy N
Nanomedicine (Lond); 2021 Aug; 16(18):1595-1611. PubMed ID: 34180261
[No Abstract] [Full Text] [Related]
8. Neuro-Immuno-Gene- and Genome-Editing-Therapy for Alzheimer's Disease: Are We There Yet?
Raikwar SP; Thangavel R; Dubova I; Ahmed ME; Selvakumar PG; Kempuraj D; Zaheer S; Iyer S; Zaheer A
J Alzheimers Dis; 2018; 65(2):321-344. PubMed ID: 30040732
[TBL] [Abstract][Full Text] [Related]
9. Emerging Promise of Immunotherapy for Alzheimer's Disease: A New Hope for the Development of Alzheimer's Vaccine.
Kabir MT; Uddin MS; Mathew B; Das PK; Perveen A; Ashraf GM
Curr Top Med Chem; 2020; 20(13):1214-1234. PubMed ID: 32321405
[TBL] [Abstract][Full Text] [Related]
10. Topical Discoveries on Multi-Target Approach to Manage Alzheimer's Disease.
Batool A; Kamal MA; Rizvi SMD; Rashid S
Curr Drug Metab; 2018; 19(8):704-713. PubMed ID: 29512457
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy in Alzheimer's disease: where do we stand? Where should we go?
von Bernhardi R
J Alzheimers Dis; 2010; 19(2):405-21. PubMed ID: 20110590
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease: early diagnosis and treatment.
Chu LW
Hong Kong Med J; 2012 Jun; 18(3):228-37. PubMed ID: 22665688
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle formulations in the diagnosis and therapy of Alzheimer's disease.
Gupta J; Fatima MT; Islam Z; Khan RH; Uversky VN; Salahuddin P
Int J Biol Macromol; 2019 Jun; 130():515-526. PubMed ID: 30826404
[TBL] [Abstract][Full Text] [Related]
14. [Gene therapy and Alzheimer's disease].
Li J; Li W; Zhou J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Apr; 40(4):428-32. PubMed ID: 25931222
[TBL] [Abstract][Full Text] [Related]
15. Fluorinated Molecules and Nanotechnology: Future 'Avengers' against the Alzheimer's Disease?
Dabur M; Loureiro JA; Pereira MC
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340267
[TBL] [Abstract][Full Text] [Related]
16. Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer's disease.
Ruthirakuhan M; Herrmann N; Suridjan I; Abraham EH; Farber I; Lanctôt KL
Expert Opin Pharmacother; 2016 Dec; 17(18):2417-2429. PubMed ID: 27825018
[TBL] [Abstract][Full Text] [Related]
17. Review of Current Strategies for Delivering Alzheimer's Disease Drugs across the Blood-Brain Barrier.
Wong KH; Riaz MK; Xie Y; Zhang X; Liu Q; Chen H; Bian Z; Chen X; Lu A; Yang Z
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658419
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease: an overview of current and emerging therapeutic strategies.
Jacobsen JS
Curr Top Med Chem; 2002 Apr; 2(4):343-52. PubMed ID: 11966458
[TBL] [Abstract][Full Text] [Related]
19. An update on Alzheimer's disease: Immunotherapeutic agents, stem cell therapy and gene editing.
Patwardhan AG; Belemkar S
Life Sci; 2021 Oct; 282():119790. PubMed ID: 34245772
[TBL] [Abstract][Full Text] [Related]
20. Immunization therapy in Alzheimer's disease.
Mor F; Monsonego A
Expert Rev Neurother; 2006 May; 6(5):653-9. PubMed ID: 16734513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
